- Home
- SRTS vs MDAI Comparison
SRTS vs MDAI Comparison
Compare SRTS & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRTS
- MDAI
- Stock Information
- Founded
- SRTS 2010
- MDAI 2013
- Country
- SRTS United States
- MDAI United States
- Employees
- SRTS N/A
- MDAI N/A
- Industry
- SRTS Medical/Dental Instruments
- MDAI Medical/Dental Instruments
- Sector
- SRTS Health Care
- MDAI Health Care
- Exchange
- SRTS Nasdaq
- MDAI Nasdaq
- Market Cap
- SRTS 75.5M
- MDAI 69.0M
- IPO Year
- SRTS 2016
- MDAI N/A
- Fundamental
- Price
- SRTS $3.39
- MDAI $1.93
- Analyst Decision
- SRTS Strong Buy
- MDAI Strong Buy
- Analyst Count
- SRTS 3
- MDAI 1
- Target Price
- SRTS $8.00
- MDAI $3.50
- AVG Volume (30 Days)
- SRTS 215.6K
- MDAI 356.4K
- Earning Date
- SRTS 08-07-2025
- MDAI 08-12-2025
- Dividend Yield
- SRTS N/A
- MDAI N/A
- EPS Growth
- SRTS N/A
- MDAI N/A
- EPS
- SRTS N/A
- MDAI N/A
- Revenue
- SRTS $37,564,000.00
- MDAI $27,549,000.00
- Revenue This Year
- SRTS N/A
- MDAI N/A
- Revenue Next Year
- SRTS $33.38
- MDAI $60.05
- P/E Ratio
- SRTS N/A
- MDAI N/A
- Revenue Growth
- SRTS 3.29
- MDAI 22.27
- 52 Week Low
- SRTS $3.03
- MDAI $0.82
- 52 Week High
- SRTS $9.33
- MDAI $3.25
- Technical
- Relative Strength Index (RSI)
- SRTS 39.05
- MDAI 34.62
- Support Level
- SRTS $3.08
- MDAI $1.98
- Resistance Level
- SRTS $3.45
- MDAI $2.14
- Average True Range (ATR)
- SRTS 0.20
- MDAI 0.15
- MACD
- SRTS 0.01
- MDAI -0.02
- Stochastic Oscillator
- SRTS 82.00
- MDAI 0.00
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.